Introduction: Atracurium besylate is bisquaternary isoquinolinium compound, a potent non depolarizing muscle relaxant of intermediate duration. Its duration of action appears not to be prolonged in absence of normal renal function. Atracurium lacks cumulative effects and its shorter duration of action and rapid recovery from block suggest that Atracurium may be suitable for continuous intravenous infusion.
Objectives: the present study was planned to compare effect of intermittent and intravenous infusion of atracurium in kidney diseases.
Methods: Eighty patients scheduled for elective surgery were randomized into two groups: A and B. Their blood urea was > 80mg/dl, S.Creatinine >2mg%.Patients were assigned randomly to atracurium either as intermittent bolus(group A, n=40) or continuous infusion(group B, n=40). During induction phase each patient was given Inj. Propofol 1.5mg/kg I.V. and was paralysed with Inj.Atracurium 0.5mg/kg I.V. Various clinical parameters are monitored and compared.
Results: In group A, the average pulse rate was 87.59±8.57mins with 9.78 percentage of intraoperative changes in pulse. While in group B the average pulse rate was 92.45±5.71mins with 6.18 percentage of intraoperative changes in pulse P = 0.002. No significant change was seen in blood pressure fluctuation. There is no significant difference in recovery time in either groups ( A : 11.1±2.2 and B : 11.4±2.6 min). The average total intraoperative dosage of atracurium in group A was 22.46±7.9 mg and the average total intraoperative dosage of atracurium in group B was 15.44±5.69 mg. (P = 0.0001).
Conclusion: Intravenous continuous infusion is suitable alternative method of administration of atracurium in renal failure patients as it provides continuous adequate steady state of anaesthesia, stable haemodynamics and lesser intraoperative dosage requirement.
Atracurium, Renal Failure, Bolus, Infusion, Blood Pressure, Pulse Rate
Application of atmospheric pressure glow discharge generated in contact with liquids for determination of chloride and bromide in water and juice samples by optical emission spectrometry.
Gorska M, Pohl P
Talanta. 2022; 237(): 122921
The DR1â€‘CSE/HS system inhibits renal fibrosis by downregulating the ERK1/2 signaling pathway in diabetic mice.
Li H, Sun F, Bai S, Chang G, Wu R, Wei Y, Wen X, Xi Y, Hao J, Zaid A
International journal of molecular medicine. 2022; 49(1):
Neutrophil-to-lymphocyte ratio in sporadic amyotrophic lateral sclerosis.
Wei QQ, Hou YB, Zhang LY, Ou RW, Cao B, Chen YP, Shang HF
Neural regeneration research. 2022; 17(4): 875-880
Radiofrequency thermocoagulation for the treatment of trigeminal neuralgia.
Wang Z, Wang Z, Li K, Su X, Du C, Tian Y
Experimental and therapeutic medicine. 2022; 23(1): 17
Blood stem cell PU.1 upregulation is a consequence of differentiation without fast autoregulation.
Ahmed N, Etzrodt M, Dettinger P, Kull T, Loeffler D, Hoppe PS, Chavez JS, Zhang Y, Camargo Ortega G, Hilsenbeck O, Nakajima H, Pietras EM, Schroeder T
The Journal of experimental medicine. 2022; 219(1):